66 completed, 7 unknown, 4 terminated, 1 temporarily not available. 29 Phase 4, 25 Phase 3, 11 Phase 2, 6 Phase 1, 1 Early Phase 1.
Follow Vardenafil Dihydrochloride: new trials by email Literature Review of Vardenafil Dihydrochloride trials Research Report on Vardenafil Dihydrochloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia Vardenafil 5 Mg Oral Tablet - Enlarged Prostate With Lower Urinary Tract Symptoms | Phase 3 | Unknown | Tanta University | 150 | 2024-06-01 | 2024-07-08 |
| Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn Vardenafil, Sildenafil - PPHN | Phase 1 / Phase 2 | Completed | Damascus University | 55 | 2023-05-01 | 2025-03-06 |
| A Healthy Volunteer Study Evaluating the the Safety, Tolerability, and Pharmacokinetics of RT234 Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI), Vardenafil Oral Tablet - Healthy Volunteer | Phase 1 | Completed | Respira Therapeutics, Inc. | 31 | 2018-07-31 | 2025-09-22 |
| Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism Testosterone - Type 2 Diabetes, Hypogonadism | Phase 4 | Terminated | Tameside Hospital NHS Foundation Trust | 22 | 2013-10-11 | 2019-04-04 |
| Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost Levitra - Pulmonary Arterial Hypertension | Phase 4 | Unknown | Rabin Medical Center | 20 | 2012-09-01 | 2012-07-25 |
| Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis Vardenafil, HVPG (Hepatic venous pressure measurement) baseline, HVPG (Hepatic venous pressure measurement) day 7 - Cirrhosis, Erectile Dysfunction | Phase 4 | Unknown | Medical University of Vienna | 30 | 2012-06-01 | 2015-09-25 |
| Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases Vardenafil, Carboplatin - Glioma, Brain Neoplasms | Early Phase 1 | Terminated | Cedars-Sinai Medical Center | 7 | 2012-03-27 | 2017-09-11 |
| Vardenafil and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV) Vardenafil, CBST - Erectile Dysfunction | Phase 4 | Completed | University of Florence | 30 | 2012-03-01 | 2018-10-16 |
| Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients? Vardenafil, Placebo - Cystic Fibrosis | Phase 2 | Terminated | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 5 | 2011-10-01 | 2019-02-25 |
| Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study Vardenafil ODT, (Staxyn, BAY38-9456), Placebo - Erectile Dysfunction | Phase 1 | Completed | Bayer | 42 | 2011-05-01 | 2014-05-19 |
| The Safety of Vardenafil in Patients Undergoing Cardiac Surgery Vardenafil - Ischemia-reperfusion Injury. | Phase 1 | Completed | McGuire Research Institute | 10 | 2010-12-01 | 2011-11-04 |
| Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors BAY60-4552 plus Vardenafil, Vardenafil, Placebo - Erectile Dysfunction | Phase 2 | Completed | Bayer | 140 | 2010-08-01 | 2014-11-04 |
| A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors PDE5 Inhibitors - Nonarteritic Anterior Ischemic Optic Neuropathy | Completed | Eli Lilly and Company | 345 | 2010-05-01 | 2018-04-05 | |
| Diabetes & Vardenafil Vardenafil, Placebo - Type 2 Diabetes Mellitus (T2DM), Endothelial Dysfunction | Phase 2 | Completed | Azienda USL Modena | 54 | 2010-03-01 | 2014-08-19 |
| Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552 BAY60-4552 + Vardenafil, Placebo - Erectile Dysfunction | Phase 1 | Completed | Bayer | 37 | 2010-01-01 | 2013-02-22 |
| Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice Vardenafil (Levitra, BAY38-9456) - Erectile Dysfunction | Completed | Bayer | 2289 | 2010-01-01 | 2016-10-17 | |
| Correlation Study of Vascular Parameters in Hypertensive Men With Erectile Dysfunction Vardenafil - Erectile Dysfunction, Arterial Hypertension | Phase 4 | Completed | Hospital Universitario Pedro Ernesto | 100 | 2010-01-01 | 2011-04-18 |
| Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome Vardenafil (Levitra, BAY38-9456), Placebo - Erectile Dysfunction, Metabolic Syndrome | Phase 4 | Completed | Bayer | 150 | 2008-11-01 | 2015-11-16 |
| Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids. Tadalafil, Vardenafil - Pulmonary Arterial Hypertension | Phase 4 | Unknown | Rabin Medical Center | 30 | 2008-08-01 | 2008-06-26 |
| A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury Vardenafil, Placebo - Erectile Dysfunction | Phase 4 | Unknown | China Rehabilitation Research Center | 350 | 2008-08-01 | 2008-07-30 |
Showing 20 of 78. Sign in to see all of them.
Erectile Dysfunction (58) · Sexual Dysfunction, Physiological (6) · Hypertension (3) · Prostatic Hyperplasia (3) · Pulmonary Arterial Hypertension (3) · Spinal Cord Injuries (3) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Hypertension, Pulmonary (2) · Acquired Immunodeficiency Syndrome (1) · Brain Neoplasms (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Cystic Fibrosis (1) · Depression (1)
Bayer (54) · Medical University of Vienna (2) · Rabin Medical Center (2) · Azienda USL Modena (1) · Cedars-Sinai Medical Center (1) · China Rehabilitation Research Center (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Damascus University (1) · Eli Lilly and Company (1) · GlaxoSmithKline (1) · Hospital Authority, Hong Kong (1) · Hospital Santa Fe (1) · Hospital Universitario Pedro Ernesto (1) · Inje University (1) · McGuire Research Institute (1)
Germany (16) · Spain (12) · United States (12) · France (9) · Belgium (8) · Italy (8) · Netherlands (7) · Canada (6) · Israel (6) · China (5) · South Africa (5) · Sweden (5) · United Kingdom (5) · Finland (4) · Poland (4)
Arnulf Ferlitsch, MD (1) · Chi Fai Ng, Dr (1) · Donna Jarlenski, MS (1) · Edward Jude, MD, MRCP (1) · Hazem B. Baz, M.B.B.Ch (1) · Ilan Gruenwald, MD (1) · Ion Jovin, MD (1) · Jae-Gook Shin (1) · Jorge Jaspersen, MD (1) · Li-Min Liao, Dr. (1) · Manuela Simoni, MD, PhD (1)
PMID 21883954, PMID 15618584, PMID 18006891, PMID 18281145, PMID 20233275, PMID 20456213, PMID 20807322, PMID 20925442, PMID 21771281, PMID 26311340, PMID 27151768, PMID 33325799
2004 (2), 2008 (2), 2005 (1), 2009 (1)